help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimoto, T.
Right arrow Articles by Kawato, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimoto, T.
Right arrow Articles by Kawato, S.
Endocrinology Vol. 142, No. 8 3578-3589
Copyright © 2001 by The Endocrine Society

ARTICLES

Neurosteroid Synthesis by Cytochrome P450-Containing Systems Localized in the Rat Brain Hippocampal Neurons: N-Methyl-D-Aspartate and Calcium-Dependent Synthesis

Tetsuya Kimoto, Tomokazu Tsurugizawa, Yoichiro Ohta, Jun’ya Makino, Hiro-omi Tamura, Yasushi Hojo, Norio Takata and Suguru Kawato

Department of Biophysics and Life Sciences, Graduate School of Arts and Sciences, University of Tokyo at Komaba (T.K., T.T., Y.O., J.M., Y.H., N.T., S.K.), Meguro, Tokyo 153, Japan; and Kyoritsu College of Pharmacy (H.T.), 1-5-30 Shibakoen, Minato, Tokyo 105, Japan

Address all correspondence and requests for reprints to: Dr. Suguru Kawato, Department of Biophysics and Life Sciences, Graduate School of Arts and Sciences, University of Tokyo at Komaba, Meguro, Tokyo 153, Japan. E-mail: kawato{at}phys.c.u-tokyo.ac.jp


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Neurosteroidogenesis has not been well elucidated due to the very low level of steroidogenic proteins in the brain. Here we report the first demonstration of the neuronal localization of neurosteroidogenic systems as well as the regulation of neurosteroidogenic activity in the adult rat hippocampus. Significant localization of cytochrome P450scc was observed in pyramidal neurons and granule neurons by means of immunohistochemical staining of slices. We also observed the colocalization, in hippocampal neurons, of P450scc with redox partners, hydroxysteroid sulfotransferase and steroidogenic acute regulatory protein. The distributions of astroglial cells and oligodendroglial cells showed very different patterns from that of the P450scc-containing cells. The expression of P450scc, redox partners, the sulfotransferase, and steroidogenic acute regulatory protein was also confirmed by Western blot analysis.

The process of active neurosteroidogenesis was stimulated by exposing neurons to N-methyl-D-aspartate. Upon stimulation with N-methyl-D-aspartate, Ca2+ influx through the N-methyl-D-aspartate subtype of glutamate receptors occurred, and significant net production of pregnenolone and pregnenolone sulfate was observed in the hippocampus. This neurosteroid production was considerably suppressed by the addition of antagonists of N-methyl-D-aspartate receptors, by Ca2+ depletion, or by the addition of an inhibitor of P450scc. Upon stimulation with N-methyl-D-aspartate, the processing of full-length steroidogenic acute regulatory protein (37-kDa) to the truncated 30-kDa steroidogenic acute regulatory protein was observed.

Taken together, these observations imply that hippocampal neurons synthesize neurosteroids. This synthesis may be stimulated and regulated by glutamate-mediated synaptic communication.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
THE HIPPOCAMPUS, which is involved essentially in learning and memory processes, is known to be a target for the neuromodulatory actions of the steroid hormones produced in the adrenal glands and gonads. Extensive studies have been performed on the role of glucocorticosteroids in modulating hippocampal plasticity and functions, because of the ability of glucocorticosteroids to reach the brain through the blood circulation after crossing the blood-brain barrier (1). In addition to hormones derived from the endocrine glands, the active de novo synthesis of neurosteroids suggests that hippocampal neurons may be exposed to locally synthesized neurosteroids, such as pregnenolone (PREG), dehydroepiandrosterone (DHEA) and their sulfated esters (PREGS and DHEAS). Recent studies reported the presence of significant amounts of neurosteroids such as PREG(S), DHEA(S), and other derivatives in the rodent cerebrum, cerebellum, and retina (2, 3, 4). Moreover, adrenalectomy did not decrease the concentrations of PREG(S) and DHEA(S) in the rodent brain (5).

In contrast to hormones derived from the circulation, there is increasing evidence that neurosteroids can modulate neurotransmission acutely in an excitatory or inhibitory manner (6). The acute actions of neurosteroids are thought to be mediated through ion-gated channel receptors rather than through the nuclear steroid receptors that promote the classic genomic actions of adrenal steroid hormones. In particular, PREGS potentiates the Ca2+ conductivity of the N-methyl-D-aspartate (NMDA) receptors (7, 8, 9) and suppresses the Cl- conductivity of the {gamma}-aminobutyric acid receptors in cultured rat hippocampal neurons (10). In combination, these actions of PREGS could facilitate excitation of the postsynaptic neurons (11).

It is plausible to assume that neurosteroid synthesis in brain cells might be partially similar to the synthesis of peripheral steroids [i.e. initiates with the transport of cholesterol into the inner mitochondrial membrane by steroidogenic acute regulatory protein (StAR) and follows with the conversion of cholesterol to PREG by cytochrome P450scc (CYP11A1)]. Cytochrome P450scc catalyzes the side-chain cleavage reaction of cholesterol, which is promoted by electron transfer from NADPH to P450scc through NADPH-adrenodoxin reductase (ADR) and adrenodoxin (ADX). PREG would then be converted to neuroactive PREGS by hydroxysteroid sulfotransferase (12).

Many studies have reported the low level expression of mRNAs, encoding for steroidogenic enzymes, in brain homogenates prepared from whole cerebrum and cerebellum. For example, the level of P450scc mRNA present in the brain homogenates was only a small fraction (i.e. 10-4–10-5) of that observed in the adrenal gland (13). However, the identity of the cell types that contained the steroidogenic enzymes was not clearly determined and has remained controversial, not only in the hippocampus but also in other regions of the brain. To enable understanding of the mode of neurosteroid action, it is clear that the cells producing neurosteroids should be determined (e.g. whether the neurosteroids are synthesized in neurons or glial cells). Although the cellular location of mRNAs encoding for several steroidogenic enzymes, such as StAR, 3ß-hydroxysteroid dehydrogenase (3ßHSD), and P450scc, was shown to be the pyramidal cells and the granule cells of the hippocampus, the clarity of P450scc mRNA hybridization in these studies was very low (14, 15).

As a discrepancy has been reported between the mRNA level and the protein level for P450scc (13), a direct investigation of the protein level should be performed for the various steroidogenic enzymes (i.e. the amounts and distribution). A fully successful direct examination of the steroidogenic proteins using immunostaining and Western blot has not yet been reported for the hippocampal cells. In addition, the net neurosteroidogenesis of PREGS from domestic cholesterol through PREG has not been demonstrated in the hippocampus, although the analysis of such activity and its regulation is essential for determining whether neurosteroids contribute significantly to the modulation of neuronal activities. Several reports along this line of investigation have appeared for the cerebellar Purkinje cells (4) and the retina (16).

In the present study to clarify the molecular mechanisms of neurosteroidogenesis in the hippocampal cells, 1) we performed a direct demonstration of cell-specific colocalization of a complete set of neurosteroidogenic enzymes responsible for PREG and PREGS production, and 2) we examined the regulatory mechanisms of neurosteroidogenesis by stimulating neurons with NMDA-receptor mediated Ca2+ influx. Because PREGS is known to potentiate NMDA receptor-mediated Ca2+ currents, we also discuss the possibility that PREGS may act as a paracrine modulator of NMDA receptors.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Materials
Bovine liver acetone powder, phenylmethylsulfonylfluoride, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen malate (MK-801), 2-amino-5-phosphonopentanoic acid (AP5), leupeptin, aminoglutethimide (AMG) and cremophor EL were purchased from Sigma (St. Louis, MO). NMDA was obtained from BIOMOL Research Laboratories, Inc. (Plymouth Meeting, PA). Normal goat serum, biotinylated goat antirabbit IgG, and avidin-horseradish peroxidase complex were obtained from Vector Laboratories, Inc. (Burlingame, CA). Cy3-labeled antimouse IgG was purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Streptavidin-Oregon Green 488 complex and fura-2/AM were obtained from Molecular Probes, Inc. (Eugene, OR). Streptavidin-horseradish peroxidase complex, C18 Amprep minicolumns, and ECL plus Western blotting detection reagents were purchased from Amersham Pharmacia Biotech (Arlington Heights, IL). Antirat P450scc antibodies, raised against a peptide sequence (amino acids 421–441) of rat P450scc (17), were obtained from Chemicon (Temecula, CA). Antibodies against neuronal nuclear antigen (NeuN), glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) were also purchased from Chemicon. [7-3H]PREG (23.5 Ci/mmol) and [7-3H]DHEAS (16.0 Ci/mmol) were obtained from NEN Life Science Products (Boston, MA). The PREG 3H RIA kit and System I Celite columns were obtained from ICN Biomedicals, Inc. (Costa Mesa, CA). Anti-StAR polyclonal antibodies raised against a peptide sequence (amino acids 88–98) of mouse StAR (18) were donated by Dr. Stocco. Anti-bovine ADR and anti-bovine ADX antibodies were donated by Dr. Hara. Purified P450scc, ADR, and ADX were provided from Drs. Kominami and Hara. Trilostane and SU-10603 were provided from Mochida Pharmaceutical (Tokyo, Japan) and Novartis (Basel, Switzerland), respectively. All other chemicals used were of the highest purity commercially available.

Preparation of rat hippocampal slices for immunohistochemistry
Adult male Wistar rats, aged 3 months (from SLC Japan Co., Shizuoka, Japan), were deeply anesthetized with pentobarbital and perfused transcardially with PBS comprised of 0.1 M phosphate buffer and 0.14 M NaCl (pH 7.3), followed by a fixative solution (4% paraformaldehyde in PBS) at 4 C. After dissection from the skulls, the hippocampi were postfixed for 24–48 h in the fixative solution at 4 C and then cryoprotected in PBS with 30% sucrose. The hippocampi were frozen-sliced coronally at 20-µm thickness with a cryostat (CM1510, Leica Corp., Heidelberg, Germany) at -17 C. All experiments using animals were conducted according to the institutional guidelines.

Immunohistochemical staining of hippocampal slices
Staining of cytochrome P450scc, hydroxysteroid sulfotransferase, and StAR was performed by the avidin-biotin-peroxidase complex technique according to the free floating method. Endogenous peroxidase activity was blocked with 0.3% H2O2 in methanol. After blocking with a PBS solution containing 5% normal goat serum, 3% fat-free skim milk, and 0.5% Triton X-100 for 2 h, the slices were treated with antirat P450scc antibodies (1:200), anti-sulfotransferase IgG (1:1000) (19), or anti-StAR IgG (1:500) for 36–48 h at 4 C in the presence of 3% skim milk and 0.5% Triton X-100. Anti-P450scc antibodies were pretreated with 0.5% liver acetone powder and 3% skim milk for 18 h at 4 C. The slices were then washed three times for 5 min each time with a PBS solution containing 0.05% Tween 20. Biotinylated antirabbit IgG diluted in a PBS solution containing 0.5% skim milk was then applied for 30 min, followed by incubation for 30 min with the avidin-horseradish peroxidase complex. Immunoreactivity was detected by immersing the slices for 2 min in a detection solution [0.1 M Tris-HCl (pH 7.2) containing 0.05% diaminobenzidine, 0.1% H2O2, and 0.3% ammonium nickel sulfate]. After dehydration and embedding, the immunoreactive cells were examined.

Fluorescence immunohistochemistry of P450scc and the sulfotransferase was carried out in the same manner as avidin-biotin-peroxidase complex staining, except that the avidin-horseradish peroxidase complex was substituted with streptavidin-Oregon Green 488 complex. The distributions of neurons, astroglial cells, and oligodendroglial cells were visualized by immunostaining with monoclonal antibodies to NeuN (1:100), GFAP (1:10,000), and MBP (1:100), respectively. Detection of neuronal/glial marker proteins was achieved with Cy3-labeled antimouse IgG without avidin-biotin amplification. Fluorescence signals were observed by an MRC-1024 confocal microscope equipped with an argon-kryton laser (Bio-Rad Laboratories, Inc., Hercules, CA). Oregon Green 488 was excited at 488 nm, and fluorescence above 522 nm was selected. Cy3 was excited at 563 nm, and emission above 605 nm was observed.

The immunoreactions of ADR (1:100,000 IgG dilution) and ADX (1:50,000 IgG dilution) were visualized by the tyramide signal amplification method (TSA-Indirect Kit, NEN Life Science Products). For preabsorption of antibodies with antigens, 30 µg/ml purified antigen proteins were used.

Preparation of mitochondrial fractions and cytosolic fractions
The hippocampus, cerebellum, testis, and lung excised from 3-month-old male Wistar rats were minced and homogenized in a glass-Teflon homogenizer (40 strokes) at 4 C in the homogenization buffer [50 mM potassium phosphate buffer (pH 7.4), 250 mM sucrose, 5 mM EDTA, 0.5 mM phenylmethylsulfonylfluoride, 0.1 mM leupeptin, and 3 mM 2mercaptoethanol]. After the removal of nuclei and debris by centrifugation at 3,000 x g for 10 min, the mitochondrial fractions were pelleted by centrifugation at 10,000 x g for 10 min (20). Purification was repeated, and the mitochondrial fractions were suspended in a 10 mM potassium phosphate buffer (pH 7.4) containing 250 mM sucrose, 5 mM MgCl2, and 20 mM KCl.

For the cytosolic fractions, homogenates were centrifuged for 90 min at 105,000 x g (19). The protein concentration was measured with a bicinchoninic acid protein determination kit (Pierce Chemical Co., Rockford, IL) using BSA as a standard.

Western immunoblot analysis
The mitochondrial fractions and cytosolic fractions were diluted to 10 mg protein/ml with a sample buffer composed of 62.5 mM Tris-HCl (pH 6.8), 6% SDS, 5% sucrose, 5% 2-mercaptoethanol, and 0.01% bromophenol blue. Samples were denatured for 5 min at 90 C and subjected to electrophoresis. Ten percent polyacrylamide gels were employed for P450scc and ADR. For ADX, the sulfotransferase, and StAR, 15%, 12%, and 12.5% polyacrylamide gels were used, respectively. After electrophoresis, proteins were transferred to polyvinylidene fluoride membranes (Immobilon-PS2, Millipore Corp., Bedford, MA) with a TE70 semidry blotting apparatus (Amersham Pharmacia Biotech) for 90 min at 2.2 mA/cm2. Blotted membranes were washed three times with PBST (PBS containing 0.05% Tween 20) and blocked for 15 min in a PBST solution containing 10% fat-free skim milk. Blots were then probed with antibodies against P450scc (1:5,000), ADR (1:5,000), ADX (1:20,000), sulfotransferase (1:5,000), and StAR (1:1,000) for 12–18 h at 4 C in PBST containing 2% skim milk. After primary antibody treatment, the blots were washed and treated with biotinylated goat antirabbit IgG (1:2,000) for 1 h. Finally, the membranes were treated with streptavidin-horseradish peroxidase complex (1:3,000) for 1 h. Biotinylated SDS-PAGE standards (Bio-Rad Laboratories, Inc.) were used as a mol wt marker. The protein bands were detected with Amersham Pharmacia Biotech ECL Plus Western blotting detection reagents. For quantitative analysis, images of the blots were captured with a scanner, and densitometric analysis was performed using NIH Image 1.61 software.

RIA of neurosteroids
Adult male Wistar rats, aged 3 months, were decapitated, and trunk blood was collected in heparinized tubes. Blood was centrifuged at 1,800 x g for 20 min at 4 C to obtain plasma. Just after the blood collection, the hippocampi were excised and transferred into low Mg2+ physiological saline [low Mg2+ PSS, composed of 137 mM NaCl, 2.5 mM CaCl2, 1 mM NaHCO3, 0.34 mM Na2HPO4, 0.44 mM KH2PO4, 5.7 mM KCl, 0.1 mM MgSO4, 22 mM glucose and 5 mM HEPES (pH 7.2)] into which O2 gas was bubbled at 4 C. The hippocampi were rinsed once and sliced into 400-µm cubes. The hippocampal cubes were then incubated at 37 C in a low Mg2+ PSS solution containing 2 µM trilostane and 20 µM SU-10603 in the presence and absence of NMDA and inhibitors such as MK-801, AP5, and AMG. Trilostane and SU-10603 were used to inhibit the further conversion of PREG to other steroids. A 30-min incubation period was used in most experiments, except for the time-course measurements. For the measurements of basal neurosteroid concentrations, incubation was omitted. For the Ca2+ depletion assay, CaCl2 was substituted by 2.7 mM EGTA. The steroidogenic reaction was terminated by adding 1 N NaOH. The hippocampal cubes were then homogenized. A trace amount of [7-3H]PREG (500 cpm) was added to monitor the recovery of PREG through the extraction and chromatographic procedures. For monitoring the recovery of PREGS through the extraction and solvolysis, [7-3H]DHEAS (500 cpm) was employed (21).

Extraction and purification of PREG(S) were performed according to Liere et al. (22) with a slight modification. Briefly, homogenates were mixed with methanol solution containing 1% acetic acid (1:10, vol/vol) and sonicated for 10 min with a sonifier (XL2020, Heat Systems, Plainview, NY). The extraction was performed overnight, after which the mixture was centrifuged at 10,000 x g for 30 min. The extraction was then repeated, the collected supernatant was combined, and the solvents were evaporated under an N2 stream. Dried residues were reconstituted in methanol-water (40:60, vol/vol) and subjected to the solid phase extraction on Amersham Pharmacia Biotech C18 Amprep minicolumns (500 mg) to separate nonconjugated steroids and sulfated steroids.

For the PREG measurements, the unconjugated steroid fractions were used. PREG was purified by Celite column chromatography (system I, ICN Biomedicals), according to the manufacturer’s instructions. PREG was then reconstituted in RIA buffer consisting of 0.15 M NaCl, 0.1% gelatin, 0.02% NaN3, and 0.1 M sodium phosphate (pH 7.0). The average PREG recovery was 65.5%. The mass of the PREG was measured by RIA using a PREG RIA kit (ICN Biomedicals, Inc.). The lower limit of PREG detection was 0.025 ng/sample. The intra- and interassay coefficients of variation were 5–8% and 11–17%, respectively. The cross-reactivity of the anti-PREG antibody with other steroids, such as deoxycorticosterone, progesterone, aldosterone, testosterone, 17ß-estradiol, corticosterone, and DHEA, was less than 0.03%, as determined by the RIA kit manufacturer.

For PREGS, the sulfated steroid fraction was used. The solvent was evaporated, and the steroids were reconstituted in ethyl acetate. Sulfuric acid was added (final concentration, 2 mM), and PREGS was converted to PREG by solvolization. After washing once with 1 N NaOH and twice with water, PREG was purified by Celite columns. Finally, the mass of PREG was measured by RIA. Recovery of PREG through Celite chromatography was monitored using [7-3H]PREG (300 cpm). The average final recovery of PREGS was 48.0%.

Measurement of Ca2+ signals with digital fluorescence microscopy
Intact slices of the hippocampus (400-µm thickness) were prepared from 3-month-old male Wistar rats with a Vibratome (Dosaka, Kyoto, Japan) for both Ca2+ measurements and electrophysiological measurements. The intracellular Ca2+ concentration was measured using fura-2 (23). Slices were loaded for 30 min at 37 C with 10 µM fura-2/AM in low Mg2+ PSS in the presence of 0.03% cremophor EL.

The slices were stimulated by perfusion with an O2-bubbled low Mg2+ PSS solution containing 100 µM NMDA at 37 C at a rate of 1.5 ml/min. We used a digital fluorescence microscope system that consisted of an inverted microscope (TMD-300, Nikon, Tokyo, Japan) equipped with a CCD camera (Hamamatsu Photonics C2400–77, Shizuoka, Japan). The excitation wavelength (340 and 380 nm) was changed every 1.15 sec with a step motor, and fluorescence above 520 nm was measured. The intracellular Ca2+ concentration was expressed as F340/F380, which is the ratio of the fura-2 fluorescence intensity at 340 nm excitation (F340) to that at 380 nm excitation (F380). Data in each area of 10 x 10 pixels were averaged with a 2.3-sec time resolution. The image analysis was performed with an ARGUS-50 system (Hamamatsu Photonics).

Electrophysiological measurements of hippocampal slices
We used a field electrophysiology apparatus. Electrical stimulation was regulated with a Master 8 controller (Axon Instruments, Foster City, CA), and signal processing and analysis were performed with a personal computer using Clamp 8 software (Axon Instruments). Intact hippocampal slices were perfused with O2-bubbled low Mg2+ PSS at 37 C at a rate of 1.5 ml/min.

Field excitatory postsynaptic potentials (EPSPs) were recorded from the stratum radiatum of CA1 with a tungsten electrode. In each case the Schaffer collateral was stimulated by a test stimulus (0.05 Hz) at an intensity adjusted to evoke a response that was 50% of the maximum EPSPs.

Data analysis
Results of RIA and the electrophysiological experiments are expressed as the mean ± SEM. Statistical significance was evaluated using Student’s t test for pairwise comparison.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Distributions of neurosteroidogenic proteins in the hippocampus
To determine the neurosteroidogenic cells in the hippocampus, we investigated the localization of cytochrome P450scc by immunohistochemical staining of the hippocampus of adult male rats (Fig. 1Go). An intense immunoreaction with antirat P450scc IgG was restricted to pyramidal neurons in the CA1–CA3 regions as well as granule cells in the dentate gyrus. Neuronal nuclear antigen staining with anti-NeuN IgG was used as a reference to determine the distribution of neurons. The somata layer of pyramidal neurons was characterized as an elongated C-shaped long curved layer throughout the CA1–CA3 regions of the hippocampus. Granule cells in the dentate gyrus showed a characteristic arrowhead-like distribution. The colocalization of immunoreactivity against P450scc and NeuN was demonstrated with fluorescence dual labeling procedures, showing that P450scc was present in pyramidal neurons. Preabsorption of the antibody with an excess of purified bovine P450scc antigen (30 µg/ml) resulted in the complete absence of P450scc immunoreactivity in all of the positively stained cells in the hippocampus (Fig. 1Go) due to cross-reaction of the antirat P450scc antibodies that we used (17). Nonimmunized serum did not cause any positive staining of the hippocampus. The localization of hydroxysteroid sulfotransferase was examined with antirat sulfotransferase IgG. The immunoreaction was restricted to pyramidal neurons and granule cells in the hippocampus, as shown in Fig. 2Go using fluorescence double labeling. Preabsorption of IgG with purified rat liver hydroxysteroid sulfotransferase resulted in the complete disappearance of immunoreactive cells.



View larger version (129K):
[in this window]
[in a new window]
  		Figure 1. Immunohistochemical staining of cytochrome P450scc in hippocampal slices of an adult male rat. A, Low magnification image of the whole hippocampus, stained with antibodies against rat cytochrome P450scc. B, The hippocampal CA1 region, stained with antibodies against rat P450scc. C, Staining with anti-P450scc IgG, preincubated with a saturated concentration of purified P450scc in the CA1 region. D, Fluorescence dual staining of P450scc (green) and NeuN (red). E, Fluorescence dual staining of P450scc (green) and GFAP (red). F, Fluorescence dual staining of P450scc (green) and MBP (red). A superimposed region of green and red fluorescence is represented in yellow. B and C, and D–F are at the same magnification. so, Stratum oriens; pcl, pyramidal cell layer; sr, stratum radiatum. A–C, Immunoreactive cells were visualized by diaminobenzidine-nickel staining. Scale bar, 800 µm (A), 120 µm (B and C), and 100 µm (D–F). Immunohistochemical experiments were performed for several different animals. In each case the same results were obtained.

 


View larger version (128K):
[in this window]
[in a new window]
  		Figure 2. Immunohistochemical staining of the hydroxysteroid sulfotransferase in hippocampal slices of an adult male rat. A, Low magnification image of the whole hippocampus, stained with antibodies against rat hydroxysteroid sulfotransferase. B, The hippocampal CA1 region, stained with antibodies against rat sulfotransferase. C, Staining with anti-sulfotransferase IgG, preincubated with a saturating concentration of purified hydroxysteroid sulfotransferase in the CA1 region. D, Fluorescence dual staining of the sulfotransferase (green) and NeuN (red). E, Fluorescence dual staining of the sulfotransferase (green) and GFAP (red). F, Fluorescence dual staining of the sulfotransferase (green) and MBP (red). A superimposed region of green and red fluorescence is represented in yellow. B and C, and D–F are at the same magnification. so, Stratum oriens; pcl, pyramidal cell layer; sr, stratum radiatum. A–C, Immunoreactive cells were visualized by diaminobenzidine-nickel staining. Scale bar, 800 µm (A), 120 µm (B and C), and 100 µm (D–F).

 
Distribution of glial cells was investigated by immunostaining of marker proteins. Antibodies against GFAP, a marker protein of astroglial cells, stained astro-shaped cells in the stratum radiatum and stratum oriens in the hippocampus. The antibodies against MBP, a marker protein of oligodendroglial cells, stained many long fibril cells in the hippocampus. Almost all cells that were immunoreactive to anti-GFAP antibodies and anti-MBP antibodies were also lacking in immunoreactivity to anti-P450scc antibodies and antisulfotransferase antibodies, indicating that most of the P450scc- and sulfotransferase-containing cells are neither astroglial cells nor oligodendroglial cells (see Figs. 1Go and 2Go).

We also investigated the presence of redox partners of P450scc in pyramidal neurons. Immunolabeling was performed for ADR and ADX, which transfer electrons to P450scc. Antibodies against ADR and ADX stained pyramidal neurons and granule cells (Fig. 3Go). These results support the hypothesis that pyramidal neurons contain a complete neurosteroidogenic system that catalyzes the conversion of cholesterol to PREG and is driven by electron transport from NADPH to P450scc through ADR and ADX. The localization of StAR protein was investigated with anti-StAR IgG. The immunoreaction was also restricted to pyramidal neurons and granule cells in the hippocampus (see Fig. 4Go).



View larger version (173K):
[in this window]
[in a new window]
  		Figure 3. Immunohistochemical staining with antibodies against ADR and ADX in the hippocampal CA1 region of an adult male rat. A, Staining with anti-ADR IgG. B, Staining with anti-ADR IgG, preabsorbed with purified ADR. C, Staining with anti-ADX IgG. D, Staining with anti-ADX IgG, preabsorbed with purified ADX. so, Stratum oriens; pcl, pyramidal cell layer; sr, stratum radiatum. Immunoreactivity was visualized by diaminobenzidine-nickel staining. Scale bar, 120 µm.

 


View larger version (156K):
[in this window]
[in a new window]
  		Figure 4. Immunohistochemical staining of StAR in the hippocampal slice of an adult male rat. Immunoreactive cells were visualized by diaminobenzidine-nickel staining. Scale bar, 800 µm.

 
Western immunoblot analysis
To demonstrate the presence of steroidogenic enzymes biochemically, we performed a Western blot analysis. The single bands for P450scc, ADR, ADX, and hydroxysteroid sulfotransferase were observed when mitochondrial fractions (for P450scc, ADR, and ADX) or cytosolic fractions (for the sulfotransferase) derived from the hippocampus were subjected to Western blotting, as illustrated in Fig. 5Go. The electrophoretic mobility of the P450scc band for the hippocampus was almost identical to that of the purified bovine adrenocortical P450scc, whose Mr was approximately 54 kDa. The Mr of ADR, ADX and the sulfotransferase were approximately 54, 12, and 30 kDa, respectively, which were close to those of bovine adrenal proteins (ADR and ADX) or rat liver proteins (hydroxysteroid sulfotransferase).



View larger version (42K):
[in this window]
[in a new window]
  		Figure 5. Western immunoblot analysis of P450scc, ADR, and ADX in mitochondria and that of hydroxysteroid sulfotransferase in cytosol. A, P450scc; B, ADR; C, ADX; D, the sulfotransferase. From left to right (A–C), the purified bovine proteins (P450scc in A, ADR in B, and ADX in C), mitochondria from rat testis, lung, cerebellum, and hippocampus. Rat lung mitochondria were used as a negative control. Purified proteins (1 ng protein each), testis mitochondria, and cerebellum mitochondria (1 µg protein each) were used as positive controls. Each lane of mitochondria from lung, cerebellum, and hippocampus contained 50 µg protein. From left to right (D), rat liver hydroxysteroid sulfotransferase (1 ng protein) and cytosol from lung and hippocampus (50 µg protein).

 
To analyze the presence of StAR in the hippocampus, mitochondria were subjected to Western blotting (see Fig. 6Go). A dense band with a Mr of approximately 37 kDa was observed in the mitochondria. For the mitochondria of bovine adrenal cortex and rat testis, a single band was observed at 30 kDa. When we subjected the mitochondria that were treated with 100 µM NMDA to Western blotting for 30 min, the density of the 37-kDa band decreased, and the density of the 30-kDa band increased. These observations imply that the full-length 37-kDa StAR was converted to 30-kDa StAR upon NMDA stimulation.



View larger version (20K):
[in this window]
[in a new window]
  		Figure 6. Western immunoblot analysis of StAR in mitochondria. A, From left to right, mitochondria from bovine adrenal cortex (1 µg protein), rat testis (1 µg protein), rat lung (50 µg protein), and rat hippocampus (50 µg protein). Rat lung mitochondria were used as a negative control. Mitochondria from bovine adrenal cortex and rat testis were used as a positive control. B, Effect of NMDA stimulation on StAR in hippocampal mitochondria. Left lane, Mitochondria incubated without NMDA for 30 min; right lane, mitochondria stimulated with 100 µM NMDA for 30 min. Upper bands and lower bands correspond to 37 and 30 kDa, respectively. Each lane contained 50 µg protein. C, Quantitative comparison for immunoblots of StAR in mitochondria derived from the hippocampus. Data are the mean ± SEM from three independent experiments and are expressed as a relative density compared with that of 37-kDa StAR bands in the mitochondria without stimulation by NMDA. *, P < 0.05 compared with the density of 30-kDa StAR in the mitochondria from the hippocampus incubated without NMDA.

 
Neurosteroidogenic activity in the rat hippocampus
We examined the activity of the neurosteroidogenic system in the adult male rat hippocampus. First, the basal concentrations of PREG and PREGS were measured in the hippocampus, cerebellum, and plasma (see Table 1Go). Significant concentrations of PREG were observed in the hippocampus (0.165 pmol/mg protein) and cerebellum (0.172 pmol/mg protein). The concentration of PREGS was 0.294 pmol/mg protein in the hippocampus. The concentrations of PREG and PREGS in the plasma were considerably lower than those in the hippocampus (see Table 1Go). The basal concentrations of PREG and PREGS in the hippocampus, cerebellum, and plasma were close to previously reported values (4, 22, 24).


View this table:
[in this window]
[in a new window]
  		Table 1. Basal concentrations of PREG and PREGS in the hippocampus, cerebellum and plasma

 
Next, the NMDA-stimulated production of neurosteroids was investigated in hippocampal tissues. Incubation of hippocampal cubes for 30 min with various concentrations of NMDA (10–500 µM) resulted in a dose-dependent increase in the concentration of PREG (Fig. 7Go). The NMDA dosage that yielded half-maximum net production of PREG (EC50) was estimated to be 45 µM by calculation using a logistic equation. We also investigated the time course of PREG production in the hippocampal cubes that were incubated in the presence of 100 µM NMDA. The PREG concentration reached a maximal value at 30 min after the NMDA application and decreased gradually thereafter (Fig. 7Go). This time course of NMDA-induced PREG production resembled that which has been observed in the retina (3). Upon stimulation with 100 µM NMDA for 30 min, the hippocampal concentration of neurosteroids increased to 0.347 pmol for PREG and 0.596 pmol for PREGS/mg protein, respectively, which is roughly twice the basal concentration. Stimulation of PREG production with NMDA was completely suppressed by the application of 50 µM MK-801 or 110 µM AP5, both of which are specific blockers of NMDA receptors (Fig. 8Go). NMDA-stimulated PREG production was also inhibited by the depletion of extracellular Ca2+, suggesting that NMDA-induced PREG production was mediated by the influx of Ca2+ through NMDA receptors. AMG (a specific inhibitor of cytochrome P450scc; 1 mM) completely blocked the PREG production induced by 100 µM NMDA stimulation, indicating that NMDA-induced PREG production in the hippocampus is solely due to the P450scc enzyme. NMDA-induced PREGS production was also inhibited by 50 µM MK-801 (see Fig. 8Go).



View larger version (12K):
[in this window]
[in a new window]
  		Figure 7. A, Dependence of the PREG production on NMDA concentrations. Hippocampal cubes were incubated with various concentrations of NMDA for 30 min. The vertical scale is the relative PREG concentration, normalized by the PREG concentration in the hippocampus, incubated for 30 min without NMDA (0.177 pmol PREG/mg protein). *, P < 0.05; **, P < 0.01 [compared with the PREG concentration, with the 30-min incubation, without NMDA stimulation]. B, Time course of PREG production after 100 µM NMDA stimulation in the hippocampal cubes. The vertical scale is the relative PREG concentration normalized by the basal PREG concentration at time zero (0.165 pmol PREG/mg protein). *, P < 0.05; **, P < 0.01 (compared with the PREG concentration at time zero). PREG was measured with specific RIA as described in Materials and Methods. Data are the mean ± SEM of four to seven independent measurements, each analyzed in duplicate.

 


View larger version (12K):
[in this window]
[in a new window]
  		Figure 8. Effect of inhibitors and Ca2+ on the synthesis of PREG and PREGS in the hippocampal cubes. A, PREG concentration. From left to right, basal PREG (without incubation), PREG after incubation in the absence of NMDA and inhibitors, PREG after incubation with 100 µM NMDA, PREG after incubation with 100 µM NMDA in the Ca2+-depleted medium, PREG after incubation with 100 µM NMDA in the presence of 50 µM MK-801, PREG after incubation with 100 µM NMDA in the presence of 110 µM AP5, and PREG after incubation with 100 µM NMDA and 1 mM AMG. B, PREGS concentration. From left to right, basal PREGS (without incubation), PREGS after incubation in the absence of NMDA and inhibitors, PREGS after incubation with 100 µM NMDA, and PREGS after incubation with 100 µM NMDA in the presence of 50 µM MK-801. All incubations were performed for 30 min at 37 C. The vertical scale in each panel is the relative PREG or PREGS concentration normalized by the basal values (0.165 pmol/mg protein for PREG and 0.294 pmol/mg protein for PREGS). Each column is the mean ± SEM of four to seven independent determinations, each analyzed in duplicate. **, P < 0.01 compared with the PREG or PREGS concentration after 30-min incubation without NMDA stimulation. PREG and PREGS were measured as described in Materials and Methods.

 
NMDA-induced Ca2+ signals in the hippocampal slices
To investigate the NMDA-induced Ca2+ influx that was occurring in the hippocampal cubic slices used for measurements of neurosteroid production, we examined the characteristics of NMDA-induced Ca2+ signals in the fura-2-loaded hippocampal slices. Transient Ca2+ elevation was observed upon stimulation with 100 µM NMDA solution. The time course of the Ca2+ transients consisted of a rapidly rising phase of 20–30 sec, followed by a slow decay phase, which reached the basal level after 10–15 min. The application of 50 µM MK-801 abolished the NMDA-induced Ca2+ signals. The peak amplitude of Ca2+ elevation, indicated as the increase in F340/F380 from the resting level [{Delta}(F340/F380)], was 0.098 ± 0.002 (mean ± SD; n = 3). These results suggest that a significant NMDA-induced Ca2+ influx may occur in the first 10–15 min of the 30-min incubation employed for the steroid production analysis.

Electrophysiological investigations of neuronal excitability
We investigated the vulnerability of neurons in the hippocampal slices under the incubation conditions used for NMDA-induced neurosteroid production by observing the EPSP of the CA1 pyramidal neurons in response to a test stimulus (50 µsec) at 0.05 Hz applied to the Schaffer collaterals. Before the application of NMDA, the mean magnitude of the EPSP peak was 0.494 ± 0.060 mV, and the mean left slope was 0.512 ± 0.103 mV/msec (n = 3). After a 30-min exposure to 100 µM NMDA, both the magnitude of the EPSP peak and the mean left slope increased significantly (by 184 ± 31% and 297 ± 47%, respectively; n = 3; P < 0.05). The mean right slope was not significantly affected, within experimental error, by the 30-min exposure to 100 µM NMDA. These results suggest that the 30-min exposure to NMDA did not considerably induce neuronal degeneration in the hippocampal slices. In a separate experiment, perfusion with 100 µM exogenous PREGS for 30 min did not attenuate, but, rather, significantly enhanced, both the mean amplitude of the EPSP peak and the mean left slope (by 158 ± 27% and 120 ± 12%, respectively; n = 3; P < 0.05). The mean right slope was again not significantly changed by the application of PREGS. Based on these results, a consideration of the excitotoxicity of PREGS and NMDA was excluded for the analysis of neurosteroid synthesis. A 100-µM PREGS solution was used, which should be a saturating concentration for the modulation of NMDA receptors, as judged from its EC50 of approximately 25–30 µM on NMDA receptors (9, 25).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In the present study we have demonstrated in the hippocampal neurons the neuronal localization of a complete neurosteroidogenic system, composed of P450scc, ADR, ADX, StAR, and hydroxysteroid sulfotransferase, with the immunohistochemical staining. We also observed significant neurosteroidogenic activity, which was dependent on the NMDA receptor-mediated Ca2+ signaling. We discuss here the possibility that this neuronal steroidogenic system functions as an NMDA- and Ca2+-dependent machinery whose products serve to modulate neuron-neuron communication as paracrine modulators.

Distribution of steroidogenic proteins and mRNAs in the hippocampus
The present study is the first demonstration of a complete neuronal steroidogenic system for PREG(S) synthesis. To date, glial cells have been considered to play a major role in neurosteroid production, because anti-P450scc antibodies were absorbed by the white matter throughout the rat brain (26, 27) and because many reports indicated the presence of P450scc (albeit at low concentration) in astrocytes and oligodendrocytes (26, 28, 29). In this study the main immunohistochemical staining for P450scc and other neurosteroidogenic proteins was observed in neurons. Therefore, the neurons are likely to play a major role in neurosteroidogenesis in the hippocampus. The possibility of glial neurosteroidogenesis was not completely excluded, because we observed a weak staining of P450scc in some glia-like cells. Previous results for the immunostaining of P450scc in the white matter are likely to be an artifact due to the nonspecific adsorption of the bovine antibodies (15). We achieved good staining by choosing suitable rat antibodies that reduced nonspecific binding in the rat hippocampus, because the concentration of P450scc was extremely low (13, 30). Specificity of the antirat P450scc antibodies used in this study was satisfactory, as judged from the Western blot analysis.

The distribution in the hippocampus of mRNAs, encoding for several steroidogenic proteins, has recently been investigated by means of in situ hybridization. Both StAR mRNA and 3ßHSD mRNA (each of approximately 10-2–10-3 of the amount in the adrenal gland) was shown to be localized along the pyramidal cell layer in the CA1–CA3 regions and the granule cell layer in the dentate gyrus (14, 15). Our results of the distribution of StAR protein were in good agreement with the reported mRNA distribution of StAR (15). Concerning the P450scc protein, its neuronal distribution in the hippocampus has previously not been well elucidated. Although the in situ hybridization analysis indicated the presence of P450scc mRNA along the pyramidal cell layer and the granule cell layer, the quality of the hybridization was much lower than that of StAR (15). To obtain detectable signals, exposure of the hybridized samples to x-ray films had to be performed for nearly 3 months. Several RT-PCR-based analyses indicated that mRNA encoding for P450scc was expressed in the brain homogenates at an extremely low level (of approximately 10-4–10-5 of that in the adrenal gland) (13, 30). The topological localization of the sulfotransferase protein was qualitatively demonstrated in the dentate gyrus of the hippocampus (12). Our finding on the sulfotransferase protein has strongly supported their previous observation by clearly demonstrating neuronal localization in the pyramidal cell layer and the granule cell layer, and a single protein band in the Western blot analysis.

Our study demonstrated the neuronal localization of a significant amount of P450scc protein as well as other neurosteroidogenic proteins in the hippocampus. From our Western blot analysis, the concentration of P450scc protein in the hippocampus was estimated to be as high as approximately 5 x 10-2 of that present in the testis and the adrenal cortex. This appears to be in agreement with the results of Mellon and Deschepper (13), which reported that the P450scc protein in the brain was roughly 10-2 of that in the adrenal gland, although the amount of P450scc mRNA in the brain was only roughly 10-4–10-5 of that in the adrenal gland. This discrepancy between the mRNA and protein concentrations may be due to a slower turnover rate for the P450scc protein in the brain than in the peripheral steroidogenic tissues (13).

Neuronal expression of the P450scc protein and the synthesis of PREG(S) has been reported in several other regions of the rat nervous system, such as retinal ganglion neurons and cerebellar Purkinje neurons (3, 4, 31). In the cerebellar Purkinje neurons and granule cells, we also observed the immunoreactivity of P450scc, StAR, and the sulfotransferase (data not shown).

Does Ca2+ influx promote neurosteroid production?
We observed that NMDA stimulated the production of PREG(S) by approximately 2-fold in the hippocampus. Because the application of NMDA also induced the influx of Ca2+ through NMDA receptors in hippocampal neurons, it is likely that Ca2+ signaling drives the neuronal steroidogenic reactions. In fact, the promotive effect of NMDA on PREG production was considerably attenuated by preventing the Ca2+ influx by means of the NMDA receptor blockers, MK-801 and AP5, and also by the direct depletion of extracellular Ca2+. We also obtained essentially the same Ca2+ dependency for PREGS synthesis. These observations suggest that NMDA-induced PREG and PREGS production in the hippocampus was mediated by the influx of Ca2+ through NMDA receptors. The influx of Ca2+ has also been reported to play a significant role in the regulation of NMDA-induced steroidogenesis in retinal tissues (3).

Judging from the many investigations reported on peripheral steroidogenesis, one of the key Ca2+-dependent processes may be cholesterol transfer, catalyzed by the StAR protein (32). We found the presence of full-length StAR (i.e. 37 kDa) in the mitochondria of the hippocampal neurons. Upon NMDA stimulation, we observed that the amount of full-length StAR decreased and the 30-kDa StAR increased in the mitochondria. This suggests that the processing of StAR may coincide with the cholesterol transfer from the outer to the inner membranes of the mitochondria. Inhibition of Ca2+ influx through NMDA receptors by MK-801 also suppressed the processing of StAR (33). These observations lead to the interpretation of a Ca2+-driven neurosteroidogenesis. It is likely that the increase in the 30-kDa StAR in the NMDA-treated hippocampus is due to some proteolytic conversion from 37-kDa StAR to 30-kDa StAR, because these phenomena appeared within 30 min of NMDA stimulation, which should be too fast for transcriptional regulation. The conversion from 37-kDa StAR to 30-kDa StAR could be catalyzed by a Ca2+-dependent proteases, although experimental evidence has not been reported to date. Even in the peripheral steroidogenic tissues, the protease responsible for the processing of StAR has not been determined, and the Ca2+-dependent and StAR-mediating cholesterol transport mechanisms have not yet been fully elucidated.

Ca2+ signaling may also be the second messenger of steroidogenesis in peripheral glands. The crucial role of Ca2+ signaling in the regulation of angiotensin II-induced steroidogenesis has been demonstrated in adrenal glomerulosa cells (34, 35). In addition, in adrenal fasciculata cells a physiological concentration of ACTH (1 pM) was observed to promote PREG production by inducing Ca2+ signals without a cAMP increase (36, 37). It should be noted that many reports have supported the conclusion that cAMP is another second messenger in ACTH-induced steroidogenesis in adrenal fasciculata cells (37, 38). The involvement of cAMP in the neuronal steroidogenesis awaits further investigation.

Concentrations of PREG and PREGS
Are the concentrations of PREGS and PREG sufficiently high so that they may act as local mediators? To examine the significance of the concentration of PREGS, we attempted to convert the dimensions from picomoles per mg protein to molar concentrations (moles per liter). We determined that 10 mg wet weight of the hippocampal tissue contained 0.96 ± 0.02 mg protein. We assumed that tissue having 1 mg wet weight has an approximate volume of 1 µl, as the major part of tissue consists of water whose 1 ml weight is 1 g. The volume should be decreased by less than 10% due to the specific volumes of proteins and lipids (~0.7–0.8 ml/g). The basal concentration of PREGS in the hippocampus is then estimated to be approximately 28 nM, and the bulk concentration of PREGS, after NMDA stimulation, is estimated to be approximately 57 nM. Because P450scc and hydroxysteroid sulfotransferase were highly localized in hippocampal neurons, the local concentration of PREGS around the neurons may be 10- to 20-fold greater than the bulk concentration (57 nM) observed after NMDA stimulation. This is due to the relatively small volume of the neurons that contained P450scc systems in the whole hippocampus, as judged from the immunostaining pattern. These considerations suggest that the local concentration of PREGS may be sufficiently high to act as a local mediator that modulates NMDA receptors (7, 8). The present basal neurosteroid concentration was close to the reported values for rodents (4, 22, 24). On the other hand, the concentration of PREGS in plasma was 4 nM. These data indicate that concentrations of PREG and PREGS in the hippocampus were 7- to 8-fold higher than those in plasma. A significant net synthesis of PREG(S) induced by the NMDA stimulation would explain the much higher concentration of hippocampal PREG(S). However, we cannot exclude the possibility that this high concentration might in part be caused by the accumulation and good retention of PREG(S) in the brain due to high levels of brain lipids, as suggested by previous studies (24, 39). It should be noted that to show the net synthesis of PREG and PREGS induced by NMDA stimulation, trilostane (3ßHSD inhibitor) and SU-10603 (P450c17 inhibitor) were employed. Without these inhibitors, the concentrations of PREG and PREGS are probably lower than the observed values due to a possible further conversion to progesterone and/or DHEA.

Possible physiological role of neurosteroids
The present results may shed light on the novel physiological role of neurosteroids as local mediators, in terms of their site of synthesis and where and how they act. PREGS may facilitate excitation of the postsynaptic neurons. PREGS enhances glutamate actions via NMDA receptors by increasing the opening probability in hippocampal neurons (7, 8, 26). In this study the concentrations of PREG and PREGS in the hippocampus were enhanced by approximately 2-fold upon stimulation with NMDA, suggesting the possibility of positive feedback between NMDA receptor activation and PREGS production. Our experimental knowledge, taken together, leads to the hypothesis that PREGS may cause postsynaptic signal amplification in the following manner: the NMDA-gating Ca2+ influx increases cholesterol transfer to the mitochondrial inner membrane by activating StAR; this is followed by the conversion of cholesterol to PREG and PREGS with P450scc systems, which increases the production of PREG and PREGS; this, in turn, potentiates the NMDA receptor-mediated Ca2+ influx.

It should be noted that a high amount of PREGS, produced by long exposure of neurons to NMDA or glutamate, may induce the excitotoxicity of neurons and result in hippocampal neuronal cell death, as has been demonstrated in the retina (3, 40). In fact, the exposure of hippocampal cubes to NMDA for longer than 30 min resulted in a decreased PREG concentration, which may have been due to the degeneration of cells. PREGS has also been shown to be excitotoxic in hippocampal cell cultures (33, 41). These results can be interpreted as the result of an enhanced Ca2+ influx induced by the PREGS through NMDA receptors (7, 8, 9). Excess Ca2+ influx was observed to cause neuronal cell death, which was also induced by an excessive exposure to glutamate, in terms of either concentration or duration (42). PREGS may function as a physiological potentiator for neuronal communication. When its concentration is too high, however, PREGS may function as an excitotoxin, leading to the cell death. This is also the case for glutamate, a reasonable concentration of which is required for normal neuronal communication. Stimulation with 100 µM NMDA for 30 min in low Mg2+ medium did not considerably attenuate the hippocampal neuronal activity, as judged from electrophysiological measurements, which supports the conclusion that many neurons were still intact under our experimental conditions.

The present experimental evidence supports the hypothesis of local neuronal synthesis of neurosteroids in the hippocampus. Although further investigations are needed, we should now consider the possibility that the neurosteroid PREGS is a local mediator that contributes to glutamate-dependent neuronal excitability in the hippocampus.


   Acknowledgments
 
We are grateful to Drs. Shiro Kominami and Takeshi Yamazaki (Hiroshima University, Hiroshima, Japan), and Dr. Takayuki Hara (Nakamura Gakuen University, Fukuoka, Japan) for the kind gifts of antibodies to ADR and ADX and of purified P450scc, ADR, and ADX. We are also grateful to Dr. Douglas M. Stocco for the kind gift of antibodies to StAR. The initial immunohistochemical experiments involving frozen slices were performed under the guidance of Dr. Ryoichi Matsuda (University of Tokyo, Tokyo, Japan). We are also grateful to Drs. K. Tsutsui, Y. Ichikawa, A. Furukawa, and T. Ohnishi for the helpful discussions. We thank Dr. John Rose for his reading of the manuscript. We also thank Mochida Pharmaceutical Co. and Novartis for providing the trilostane and SU-10603, respectively.


   Footnotes
 
This work was supported by grants from the Ministry of Education, Science, and Culture in Japan (to T.K. and S.K.).

Abbreviations: ADR, NADPH-adrenodoxin reductase; ADX, adrenodoxin; AP5, 2-amino-5-phosphonopentanoic acid; AMG, aminoglutethimide; DHEA, dehydroepiandrosterone; DHEAS, DHEA sulfate; EPSP, excitatory postsynaptic potential; GFAP, glial fibrillary acidic protein; 3ßHSD, 3ß-hydroxysteroid dehydrogenase; MBP, myelin basic protein; MK-801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen malate; NeuN, neuronal nuclear antigen; NMDA, N-methyl-D-aspartate; PBST, PBS containing 0.05% Tween 20; PREG, pregnenolone; PREGS, PREG sulfate; PSS, physiological saline; StAR, steroidogenic acute regulatory protein.

Received November 10, 2000.

Accepted for publication April 13, 2001.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McEwen BS 1999 Stress and hippocampal plasticity. Annu Rev Neurosci 22:105–122[CrossRef][Medline]
  2. Baulieu E-E 1997 Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1–32
  3. Guarneri P, Russo D, Cascio C, De Leo G, Piccoli F, Guarneri R 1998 Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in exocitotoxicity. Eur J Neurosci 10:1752–1763[CrossRef][Medline]
  4. Ukena K, Usui M, Kohchi C, Tsutsui K 1998 Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neuronal change in rats. Endocrinology 139:137–147[Abstract/Free Full Text]
  5. Robel P, Bourreau E, Corpechot C, et al. 1987 Neuro-steroids: 3ß-hydroxy-{Delta}5-derivatives in rat and monkey brain. J Steroid Biochem 27:649–655[CrossRef][Medline]
  6. Schumacher M, Guennoun R, Robel P, Baulieu E-E 1997 Neurosteroids in the hippocampus: neuronal plasticity and memory. Stress 2:65–78[Medline]
  7. Irwin RP, Maragakis NJ, Rogawski MA, Purdy RH, Farb DH, Paul SM 1992 Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neurosci Lett 141:30–34[CrossRef][Medline]
  8. Fahey JM, Lindquist DG, Pritchard GA, Miller LG 1995 Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res 669:183–188[CrossRef][Medline]
  9. Mukai H, Uchino S, Kawato S 2000 Effects of neurosteroids on Ca2+ signaling mediated by recombinant N-methyl-D-aspartate receptor expressed in Chinese hamster ovary cells. Neurosci Lett 282:93–96[CrossRef][Medline]
  10. Harrison NL, Vicini S, Barker JL 1987 A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurosci 7:604–609[Abstract]
  11. Wu FS, Gibbs TT, Farb DH 1991 Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 40:333–336[Abstract]
  12. Rajkowski KM, Robel P, Baulieu E-E 1997 Hydroxysteroid sulfotransferase activity in the rat brain and liver as a function of age and sex. Steroids 62:427–436[CrossRef][Medline]
  13. Mellon SH, Deschepper CF 1993 Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 629:283–292[CrossRef][Medline]
  14. Guennoun R, Fiddes RJ, Gouezou M, Lombes M, Baulieu E-E 1995 A key enzyme in the biosynthesis of neurosteroids, 3ß-hydroxysteroid dehydrogenase/{Delta}5-{Delta}4-isomerase (3ß-HSD), is expressed in rat brain. Mol Brain Res 30:287–300[Medline]
  15. Furukawa A, Miyatake A, Ohnishi T, Ichikawa Y 1998 Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450scc (CYP XIA1), and 3ß-hydroxysteroid dehydrogenase in the rat brain. J Neurochem 71:2231–2238[Medline]
  16. Guarneri P, Guarneri R, Cascio C, Pavasant P, Piccoli F, Papadopoulos V 1994 Neurosteroidogenesis in rat retinas. J Neurochem 63:86–96[Medline]
  17. Roby KF, Larsen D, Deb S, Soares MJ 1991 Generation and characterization of antipeptide antibodies to rat cytochrome P-450 side-chain cleavage enzyme. Mol Cell Endocrinol 79:13–20[CrossRef][Medline]
  18. Clark BJ, Wells J, King SR, Stocco DM 1994 The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells: characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 269:28314–28322[Abstract/Free Full Text]
  19. Takahashi M, Tamura H, Kondo S, Kobayashi K, Matsui M 1998 Identification of three hydroxysteroid sulfotransferase isoenzymes in the rat liver. Biol Pharm Bull 21:10–15[Medline]
  20. Hatefy Y, Lester RL 1958 Studies on the mechanism of oxidative phosphorylation. III. Phosphorylating particle types from beef heart. Biochim Biophys Acta 27:83–88
  21. Corpechot C, Synguelakis M, Talha S, et al. 1983 Pregnenolone and its sulfate ester in rat brain. Brain Res 270:119–125[CrossRef][Medline]
  22. Liere P, Akwa Y, Weill-Engerer S, et al. 2000 Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J Chromatogr B 739:301–312
  23. Grynkiewicz G, Poenie M, Tsien RY 1985 A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450[Abstract/Free Full Text]
  24. Wang M-D, Wahlstrom G, Backstrom T 1997 The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J Steroid Biochem Mol Biol 62:299–306[CrossRef][Medline]
  25. Bowlby MR 1993 Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43:813–819[Abstract]
  26. Le Goascogne C, Robel P, Gouezou M, Sananes N, Baulieu E-E, Waterman M 1987 Neurosteroids: cytochrome P-450scc in rat brain. Science 237:1212–1215[Abstract/Free Full Text]
  27. Iwahashi K, Ozaki HS, Tsubaki M, Ohnishi J, Takeuchi Y, Ichikawa Y 1990 Studies of the immunohistochemical and biochemical localization of the cytochrome P-450scc-linked monooxygenase system in the adult rat brain. Biochim Biophys Acta 1035:182–189[Medline]
  28. Jung-Testas I, Hu ZY, Baulieu E-E, Robel P 1989 Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 125:2083–2091[Abstract]
  29. Kimoto T, Asou H, Ohta Y, Mukai H, Chernogolov AA, Kawato S 1997 Digital fluorescence imaging of elementary steps of neurosteroid synthesis in rat brain glial cells. J Pharm Biomed Anal 15:1231–1240[CrossRef][Medline]
  30. Sanne JL, Krueger KE 1995 Expression of cytochrome P450 side-chain cleavage enzyme and 3ß-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J Neurochem 65:528–536[Medline]
  31. Ukena K, Kohchi C, Tsutsui K 1999 Expression and activity of 3ß-hydroxysteroid dehydrogenase/{Delta}5-{Delta}4-isomerase in the rat Purkinje neuron during neonatal life. Endocrinology 140:805–813[Abstract/Free Full Text]
  32. Cherradi N, Rossier MF, Vallotton MB, et al. 1997 Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3ß-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem 272:7899–7907[Abstract/Free Full Text]
  33. Kawato S, Yamada M, Kimoto T Neurosteroids are 4th generation neuromessengers: cell biophysics analysis of steroid signal transduction. Adv Biophys, in press
  34. Python CP, Laban OP, Rossier MF, Vallotton MB, Capponi AM 1995 The site of action of Ca2+ in the activation of steroidogenesis: studies in Ca2+-clamped bovine adrenal zona-glomerulosa cells. Biochem J 305:569–576
  35. Foster RH, MacFarlane CH, Bustamante MO 1997 Recent progress in understanding aldosterone secretion. Gen Pharmacol 28:647–651[Medline]
  36. Kimoto T, Ohta Y, Kawato S 1996 Adrenocorticotropin induces calcium oscillations in adrenal fasciculata cells: single cell imaging. Biochem Biophys Res Commun 221:25–30[CrossRef][Medline]
  37. Yamazaki T, Kimoto T, Higuchi K, Ohta Y, Kawato S, Kominami S 1998 Calcium ion as a second messenger for o-nitrophenylsulfenyl-adrenocorticotropin (NPS-ACTH) and ACTH in bovine adrenal steroidogenesis. Endocrinology 139:4765–4771[Abstract/Free Full Text]
  38. Yanagibashi K, Papadopoulos V, Masaki E, Iwaki T, Kawamura M, Hall PF 1989 Forskolin activates voltage-dependent Ca2+ channels in bovine but not in rat fasciculata cells. Endocrinology 124:2383–2391[Abstract]
  39. Wade GN, Feder HH 1972 Uptake of [1,2-3H]20{alpha}-hydroxypregn-4-en-3-one, [1,2-3H]corticosterone, and [6,7-3H]estradiol-17ß by guinea pig brain and uterus: comparison with uptake of [1,2-3H]progesterone. Brain Res 45:545–554[CrossRef][Medline]
  40. Cascio C, Guarneri R, Russo D, et al. 2000 Pregnenolone sulfate, a naturally occurring excitotoxin involved in delayed retinal cell death. J Neurochem 74:2380–2391[CrossRef][Medline]
  41. Weaver Jr CE, Farb DH 1995 Steroid modulation of NMDA-induced cell death in primary cultures of rat hippocampal neurons. Soc Neurosci Abstr 21:73
  42. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J 1998 Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852–1857[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 EndocrinologyHome page
K. Tsutsui
Progesterone Biosynthesis and Action in the Developing Neuron
Endocrinology, June 1, 2008; 149(6): 2757 - 2761.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. M. McCARTHY
Estradiol and the Developing Brain
Physiol Rev, January 1, 2008; 88(1): 91 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
L. Chen, Y. Miyamoto, K. Furuya, N. Mori, and M. Sokabe
PREGS Induces LTP in the Hippocampal Dentate Gyrus of Adult Rats Via the Tyrosine Phosphorylation International Cooperative Research CREB Signaling
J Neurophysiol, September 1, 2007; 98(3): 1538 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
H. Ish, T. Tsurugizawa, M. Ogiue-Ikeda, M. Asashima, H. Mukai, G. Murakami, Y. Hojo, T. Kimoto, and S. Kawato
Local Production of Sex Hormones and Their Modulation of Hippocampal Synaptic Plasticity
Neuroscientist, August 1, 2007; 13(4): 323 - 334.
[Abstract] [PDF]

Home page
 J. Neurophysiol.Home page
Y. B. Saalmann, I. G. Morgan, and M. B. Calford
Neurosteroids Involved in Regulating Inhibition in the Inferior Colliculus
J Neurophysiol, December 1, 2006; 96(6): 3064 - 3073.
[Abstract] [Full Text] [PDF]